<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">30487421</PMID><DateCompleted><Year>2019</Year><Month>02</Month><Day>12</Day></DateCompleted><DateRevised><Year>2020</Year><Month>03</Month><Day>09</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1999-4915</ISSN><JournalIssue CitedMedium="Internet"><Volume>10</Volume><Issue>12</Issue><PubDate><Year>2018</Year><Month>Nov</Month><Day>28</Day></PubDate></JournalIssue><Title>Viruses</Title><ISOAbbreviation>Viruses</ISOAbbreviation></Journal><ArticleTitle>Immunocompetent and Immunodeficient Mouse Models for Enterovirus 71 Pathogenesis and Therapy.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">674</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/v10120674</ELocationID><Abstract><AbstractText>Enterovirus 71 (EV71) is a global health threat. Children infected with EV71 could develop hand-foot-and-mouth disease (HFMD), encephalitis, paralysis, pulmonary edema, and death. At present, no effective treatment for EV71 is available. We reviewed here various mouse models for EV71 pathogenesis and therapy. Earlier studies relied on the use of mouse-adapted EV71 strains. To avoid artificial mutations arising de novo during the serial passages, recent studies used EV71 clinical isolates without adaptation. Several human receptors for EV71 were shown to facilitate viral entry in cell culture. However, in vivo infection with human SCARB2 receptor transgenic mice appeared to be more limited to certain strains and genotypes of EV71. Efficacy of oral infection in these transgenic models is extremely low. Intriguingly, despite the lack of human receptors, immunodeficient neonatal mouse models can still be infected with EV71 clinical isolates via oral or intraperitoneal routes. Crossbreeding between SCARB2 transgenic and stat1 knockout mice generated a more sensitive and user-friendly hybrid mouse model. Infected hybrid mice developed a higher incidence and earlier onset of CNS disease and death. Different pathogenesis profiles were observed in models deficient in various arms of innate or humoral immunity. These models are being actively used for antiviral research.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Shih</LastName><ForeName>Chiaho</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Institute of Biomedical Sciences, Academia Sinica, Taipei 11529, Taiwan. cshih@ibms.sinica.edu.tw.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liao</LastName><ForeName>Chun-Che</ForeName><Initials>CC</Initials><AffiliationInfo><Affiliation>Institute of Biomedical Sciences, Academia Sinica, Taipei 11529, Taiwan. jfliao@ibms.sinica.edu.tw.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chang</LastName><ForeName>Ya-Shu</ForeName><Initials>YS</Initials><AffiliationInfo><Affiliation>Institute of Biomedical Sciences, Academia Sinica, Taipei 11529, Taiwan. daph7516@gmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Szu-Yao</ForeName><Initials>SY</Initials><AffiliationInfo><Affiliation>Institute of Biomedical Sciences, Academia Sinica, Taipei 11529, Taiwan. guguma126@yahoo.com.tw.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chang</LastName><ForeName>Chih-Shin</ForeName><Initials>CS</Initials><AffiliationInfo><Affiliation>Institute of Biomedical Sciences, Academia Sinica, Taipei 11529, Taiwan. sony721108@hotmail.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Microbiology and Immunology, National Yang-Ming University, Taipei 11221, Taiwan. sony721108@hotmail.com.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liou</LastName><ForeName>An-Ting</ForeName><Initials>AT</Initials><AffiliationInfo><Affiliation>Institute of Biomedical Sciences, Academia Sinica, Taipei 11529, Taiwan. sh3333@msn.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2018</Year><Month>11</Month><Day>28</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Viruses</MedlineTA><NlmUniqueID>101509722</NlmUniqueID><ISSNLinking>1999-4915</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D014765">Viral Vaccines</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002460" MajorTopicYN="N">Cell Line</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="N">Enterovirus A, Human</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D004769" MajorTopicYN="N">Enterovirus Infections</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName><QualifierName UI="Q000821" MajorTopicYN="N">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D005838" MajorTopicYN="N">Genotype</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D054884" MajorTopicYN="N">Host-Pathogen Interactions</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="Y">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007114" MajorTopicYN="N">Immunization</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016867" MajorTopicYN="Y">Immunocompromised Host</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008822" MajorTopicYN="N">Mice, Transgenic</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D014765" MajorTopicYN="N">Viral Vaccines</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D014779" MajorTopicYN="N">Virus Replication</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">EV-A71</Keyword><Keyword MajorTopicYN="N">EV71</Keyword><Keyword MajorTopicYN="N">Enterovirus 71</Keyword><Keyword MajorTopicYN="N">animal models</Keyword><Keyword MajorTopicYN="N">pathogenesis</Keyword><Keyword MajorTopicYN="N">therapy</Keyword></KeywordList><CoiStatement>We declare no competing financial interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>11</Month><Day>1</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2018</Year><Month>11</Month><Day>23</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2018</Year><Month>11</Month><Day>26</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2018</Year><Month>11</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2018</Year><Month>11</Month><Day>30</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2019</Year><Month>2</Month><Day>13</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2018</Year><Month>12</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">30487421</ArticleId><ArticleId IdType="pmc">PMC6316343</ArticleId><ArticleId IdType="doi">10.3390/v10120674</ArticleId><ArticleId IdType="pii">v10120674</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Schmidt N.J., Lennette E.H., Ho H.H. An apparently new enterovirus isolated from patients with disease of the central nervous system. J. Infect. Dis. 1974;129:304&#x2013;309. doi: 10.1093/infdis/129.3.304.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/129.3.304</ArticleId><ArticleId IdType="pubmed">4361245</ArticleId></ArticleIdList></Reference><Reference><Citation>Brown B.A., Pallansch M.A. Complete nucleotide sequence of enterovirus 71 is distinct from poliovirus. Virus Res. 1995;39:195&#x2013;205. doi: 10.1016/0168-1702(95)00087-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0168-1702(95)00087-9</ArticleId><ArticleId IdType="pubmed">8837884</ArticleId></ArticleIdList></Reference><Reference><Citation>Cox J.A., Hiscox J.A., Solomon T., Ooi M.H., Ng L.F.P. Immunopathogenesis and virus-host interactions of enterovirus 71 in patients with hand, foot and mouth disease. Front. Microbiol. 2017;8:2249. doi: 10.3389/fmicb.2017.02249.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2017.02249</ArticleId><ArticleId IdType="pmc">PMC5713468</ArticleId><ArticleId IdType="pubmed">29238324</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao C.C., Liou A.T., Chang Y.S., Wu S.Y., Chang C.S., Lee C.K., Kung J.T., Tu P.H., Yu Y.Y., Lin C.Y., et al. Immunodeficient mouse models with different disease profiles by in vivo infection with the same clinical isolate of enterovirus 71. J. Virol. 2014;88:12485&#x2013;12499. doi: 10.1128/JVI.00692-14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00692-14</ArticleId><ArticleId IdType="pmc">PMC4248922</ArticleId><ArticleId IdType="pubmed">25142603</ArticleId></ArticleIdList></Reference><Reference><Citation>Liou A.-T., Wu S.-Y., Liao C.-C., Chang Y.-S., Chang C.-S., Shih C. A new animal model containing human SCARB2 and lacking stat-1 is highly susceptible to EV71. Sci. Rep. 2016;6:31151. doi: 10.1038/srep31151.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep31151</ArticleId><ArticleId IdType="pmc">PMC4976353</ArticleId><ArticleId IdType="pubmed">27499235</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho M., Chen E.R., Hsu K.H., Twu S.J., Chen K.T., Tsai S.F., Wang J.R., Shih S.R. An epidemic of enterovirus 71 infection in Taiwan. N. Engl. J. Med. 1999;341:929&#x2013;935. doi: 10.1056/NEJM199909233411301.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM199909233411301</ArticleId><ArticleId IdType="pubmed">10498487</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang L.-Y., Huang L.-M., Gau S.S.-F., Wu Y.-Y., Hsia S.-H., Fan T.-Y., Lin K.-L., Huang Y.-C., Lu C.-Y., Lin T.-Y. Neurodevelopment and cognition in children after enterovirus 71 infection. N. Engl. J. Med. 2007;356:1226&#x2013;1231. doi: 10.1056/NEJMoa065954.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa065954</ArticleId><ArticleId IdType="pubmed">17377160</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu J.-M., Wang J.-N., Tsai Y.-C., Liu C.-C., Huang C.-C., Chen Y.-J., Yeh T.-F. Cardiopulmonary manifestations of fulminant enterovirus 71 infection. Pediatrics. 2002;109:e26. doi: 10.1542/peds.109.2.e26.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.109.2.e26</ArticleId><ArticleId IdType="pubmed">11826236</ArticleId></ArticleIdList></Reference><Reference><Citation>Shimizu H., Utama A., Onnimala N., Li C., Zhang L.-B., Ma Y.-J., Pongsuwanna Y., Miyamura T. Molecular epidemiology of enterovirus 71 infection in the western pacific region. Pediatr. Int. 2004;46:231&#x2013;235. doi: 10.1046/j.1442-200x.2004.01868.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1046/j.1442-200x.2004.01868.x</ArticleId><ArticleId IdType="pubmed">15056257</ArticleId></ArticleIdList></Reference><Reference><Citation>Mizuta K., Aoki Y., Matoba Y., Yahagi K., Itagaki T., Katsushima F., Katsushima Y., Ito S., Hongo S., Matsuzaki Y. Molecular epidemiology of enterovirus 71 strains isolated from children in Yamagata, Japan, between 1990 and 2013. J. Med. Microbiol. 2014;63:1356&#x2013;1362. doi: 10.1099/jmm.0.079699-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/jmm.0.079699-0</ArticleId><ArticleId IdType="pubmed">25053796</ArticleId></ArticleIdList></Reference><Reference><Citation>AbuBakar S., Chee H.Y., Al-Kobaisi M.F., Xiaoshan J., Chua K.B., Lam S.K. Identification of enterovirus 71 isolates from an outbreak of hand, foot and mouth disease (HFMD) with fatal cases of encephalomyelitis in malaysia. Virus Res. 1999;61:1&#x2013;9. doi: 10.1016/S0168-1702(99)00019-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0168-1702(99)00019-2</ArticleId><ArticleId IdType="pubmed">10426204</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y., Feng Z., Yang Y., Self S., Gao Y., Longini I.M., Wakefield J., Zhang J., Wang L., Chen X., et al. Hand, foot, and mouth disease in china: Patterns of spread and transmissibility. Epidemiology. 2011;22:781&#x2013;792. doi: 10.1097/EDE.0b013e318231d67a.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/EDE.0b013e318231d67a</ArticleId><ArticleId IdType="pmc">PMC3246273</ArticleId><ArticleId IdType="pubmed">21968769</ArticleId></ArticleIdList></Reference><Reference><Citation>Fischer T.K., Nielsen A.Y., Sydenham T.V., Andersen P.H., Andersen B., Midgley S.E. Emergence of enterovirus 71 C4a in Denmark, 2009 to 2013. Eurosurveillance. 2014;19:20911. doi: 10.2807/1560-7917.ES2014.19.38.20911.</Citation><ArticleIdList><ArticleId IdType="doi">10.2807/1560-7917.ES2014.19.38.20911</ArticleId><ArticleId IdType="pubmed">25306878</ArticleId></ArticleIdList></Reference><Reference><Citation>Medici M.C., Tummolo F., Arcangeletti M.C., De Conto F., Chezzi C., Dodi I., Calderaro A. A cluster of enterovirus 71 subgenogroup C2 in a nursery school, Italy, 2014. New Microbiol. 2016;39:295&#x2013;298.</Citation><ArticleIdList><ArticleId IdType="pubmed">27455182</ArticleId></ArticleIdList></Reference><Reference><Citation>Akhmadishina L.V., Eremeeva T.P., Trotsenko O.E., Ivanova O.E., Mikhailov M.I., Lukashev A.N. Seroepidemiology and molecular epidemiology of enterovirus 71 in Russia. PLoS ONE. 2014;9:e97404. doi: 10.1371/journal.pone.0097404.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0097404</ArticleId><ArticleId IdType="pmc">PMC4018281</ArticleId><ArticleId IdType="pubmed">24819617</ArticleId></ArticleIdList></Reference><Reference><Citation>Zander A., Britton P.N., Navin T., Horsley E., Tobin S., McAnulty J.M. An outbreak of enterovirus 71 in metropolitan Sydney: Enhanced surveillance and lessons learnt. Med. J. Aust. 2014;201:663&#x2013;666. doi: 10.5694/mja14.00014.</Citation><ArticleIdList><ArticleId IdType="doi">10.5694/mja14.00014</ArticleId><ArticleId IdType="pubmed">25495312</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S.M., Lei H.Y., Huang M.C., Su L.Y., Lin H.C., Yu C.K., Wang J.L., Liu C.C. Modulation of cytokine production by intravenous immunoglobulin in patients with enterovirus 71-associated brainstem encephalitis. J. Clin. Virol. 2006;37:47&#x2013;52. doi: 10.1016/j.jcv.2006.05.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2006.05.009</ArticleId><ArticleId IdType="pubmed">16861032</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao R.Y., Dong D.Y., Liu R.J., Han J.F., Wang G.C., Zhao H., Li X.F., Deng Y.Q., Zhu S.Y., Wang X.Y., et al. Human igg subclasses against enterovirus type 71: Neutralization versus antibody dependent enhancement of infection. PLoS ONE. 2013;8:e64024. doi: 10.1371/journal.pone.0064024.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0064024</ArticleId><ArticleId IdType="pmc">PMC3659118</ArticleId><ArticleId IdType="pubmed">23700449</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S.M., Chen I.C., Su L.Y., Huang K.J., Lei H.Y., Liu C.C. Enterovirus 71 infection of monocytes with antibody-dependent enhancement. Clin. Vaccine Immunol. 2010;17:1517&#x2013;1523. doi: 10.1128/CVI.00108-10.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/CVI.00108-10</ArticleId><ArticleId IdType="pmc">PMC2953001</ArticleId><ArticleId IdType="pubmed">20685937</ArticleId></ArticleIdList></Reference><Reference><Citation>Han J.F., Cao R.Y., Deng Y.Q., Tian X., Jiang T., Qin E.D., Qin C.F. Antibody dependent enhancement infection of enterovirus 71 in vitro and in vivo. Virol. J. 2011;8:106. doi: 10.1186/1743-422X-8-106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1743-422X-8-106</ArticleId><ArticleId IdType="pmc">PMC3060144</ArticleId><ArticleId IdType="pubmed">21385398</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen I.C., Wang S.-M., Yu C.-K., Liu C.-C. Subneutralizing antibodies to enterovirus 71 induce antibody-dependent enhancement of infection in newborn mice. Med. Microbiol. Immunol. 2013;202:259&#x2013;265. doi: 10.1007/s00430-013-0289-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00430-013-0289-y</ArticleId><ArticleId IdType="pubmed">23408291</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang S.M., Lei H.Y., Huang M.C., Wu J.M., Chen C.T., Wang J.N., Wang J.R., Liu C.C. Therapeutic efficacy of milrinone in the management of enterovirus 71-induced pulmonary edema. Pediatr. Pulmonol. 2005;39:219&#x2013;223. doi: 10.1002/ppul.20157.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ppul.20157</ArticleId><ArticleId IdType="pubmed">15635619</ArticleId></ArticleIdList></Reference><Reference><Citation>Han J.F., Cao R.Y., Tian X., Yu M., Qin E.D., Qin C.F. Producing infectious enterovirus type 71 in a rapid strategy. Virol. J. 2010;7:116. doi: 10.1186/1743-422X-7-116.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1743-422X-7-116</ArticleId><ArticleId IdType="pmc">PMC2892457</ArticleId><ArticleId IdType="pubmed">20525351</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu P., Bao L., Xu L., Li F., Lv Q., Deng W., Xu Y., Qin C. Neurotropism in vitro and mouse models of severe and mild infection with clinical strains of enterovirus 71. Viruses. 2017;9:351. doi: 10.3390/v9110351.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/v9110351</ArticleId><ArticleId IdType="pmc">PMC5707558</ArticleId><ArticleId IdType="pubmed">29156632</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang C., Ji L., Yuan X., Jin Y., Cardona C.J., Xing Z. Differential regulation of tlr signaling on the induction of antiviral interferons in human intestinal epithelial cells infected with enterovirus 71. PLoS ONE. 2016;11:e0152177. doi: 10.1371/journal.pone.0152177.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0152177</ArticleId><ArticleId IdType="pmc">PMC4805281</ArticleId><ArticleId IdType="pubmed">27007979</ArticleId></ArticleIdList></Reference><Reference><Citation>Lui Y.L.E., Timms P., Hafner L.M., Tan T.L., Tan K.H., Tan E.L. Characterisation of enterovirus 71 replication kinetics in human colorectal cell line, HT29. SpringerPlus. 2013;2:267. doi: 10.1186/2193-1801-2-267.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/2193-1801-2-267</ArticleId><ArticleId IdType="pmc">PMC3696168</ArticleId><ArticleId IdType="pubmed">23875129</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang Y.F., Chou C.T., Lei H.Y., Liu C.C., Wang S.M., Yan J.J., Su I.J., Wang J.R., Yeh T.M., Chen S.H., et al. A mouse-adapted enterovirus 71 strain causes neurological disease in mice after oral infection. J. Virol. 2004;78:7916&#x2013;7924. doi: 10.1128/JVI.78.15.7916-7924.2004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.78.15.7916-7924.2004</ArticleId><ArticleId IdType="pmc">PMC446098</ArticleId><ArticleId IdType="pubmed">15254164</ArticleId></ArticleIdList></Reference><Reference><Citation>Xing Z., Huang H.-I., Chio C.-C., Lin J.-Y. Inhibition of EV71 by curcumin in intestinal epithelial cells. PLoS ONE. 2018;13:e0191617.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5784943</ArticleId><ArticleId IdType="pubmed">29370243</ArticleId></ArticleIdList></Reference><Reference><Citation>Ang L.Y.E., Too H.K.I., Tan E.L., Chow T.-K.V., Shek P.-C.L., Tham E., Alonso S. Antiviral activity of lactobacillus reuteri protectis against coxsackievirus A and enterovirus 71 infection in human skeletal muscle and colon cell lines. Virol. J. 2016;13:111. doi: 10.1186/s12985-016-0567-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12985-016-0567-6</ArticleId><ArticleId IdType="pmc">PMC4920999</ArticleId><ArticleId IdType="pubmed">27341804</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y., Zheng Z., Shu B., Meng J., Zhang Y., Zheng C., Ke X., Gong P., Hu Q., Wang H., et al. Sumo modification stabilizes enterovirus 71 polymerase 3D to facilitate viral replication. J. Virol. 2016;90:10472&#x2013;10485. doi: 10.1128/JVI.01756-16.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01756-16</ArticleId><ArticleId IdType="pmc">PMC5110190</ArticleId><ArticleId IdType="pubmed">27630238</ArticleId></ArticleIdList></Reference><Reference><Citation>Du X., Wang H., Xu F., Huang Y., Liu Z., Liu T.E. Enterovirus 71 induces apoptosis of SH-SY5Y human neuroblastoma cells through stimulation of endogenous microRNA let-7b expression. Mol. Med. Rep. 2015;12:953&#x2013;959. doi: 10.3892/mmr.2015.3482.</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/mmr.2015.3482</ArticleId><ArticleId IdType="pmc">PMC4438926</ArticleId><ArticleId IdType="pubmed">25779425</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu L.J., Jiang T., Zhang F.J., Han J.F., Liu J., Zhao H., Li X.F., Liu R.J., Deng Y.Q., Wu X.Y., et al. Global transcriptomic analysis of human neuroblastoma cells in response to enterovirus type 71 infection. PLoS ONE. 2013;8:e65948. doi: 10.1371/journal.pone.0065948.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0065948</ArticleId><ArticleId IdType="pmc">PMC3702535</ArticleId><ArticleId IdType="pubmed">23861741</ArticleId></ArticleIdList></Reference><Reference><Citation>Too I.H.K., Yeo H., Sessions O.M., Yan B., Libau E.A., Howe J.L.C., Lim Z.Q., Suku-Maran S., Ong W.-Y., Chua K.B., et al. Enterovirus 71 infection of motor neuron-like NSC-34 cells undergoes a non-lytic exit pathway. Sci. Rep. 2016;6:36983. doi: 10.1038/srep36983.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep36983</ArticleId><ArticleId IdType="pmc">PMC5111112</ArticleId><ArticleId IdType="pubmed">27849036</ArticleId></ArticleIdList></Reference><Reference><Citation>Shih S.-R., Weng K.-F., Stollar V., Li M.-L. Viral protein synthesis is required for enterovirus 71 to induce apoptosis in human glioblastoma cells. J. Neurovirol. 2008;14:53&#x2013;61. doi: 10.1080/13550280701798980.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/13550280701798980</ArticleId><ArticleId IdType="pubmed">18300075</ArticleId></ArticleIdList></Reference><Reference><Citation>Tse H., Victorio C.B.L., Xu Y., Ng Q., Chow V.T.K., Chua K.B. Phenotypic and genotypic characteristics of novel mouse cell line (NIH/3T3)-adapted human enterovirus 71 strains (EV71:TLLm and EV71:TLLmv) PLoS ONE. 2014;9:e92719.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3966832</ArticleId><ArticleId IdType="pubmed">24671184</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang B., Xi X., Lei X., Zhang X., Cui S., Wang J., Jin Q., Zhao Z. Enterovirus 71 protease 2Apro targets MAVS to inhibit anti-viral type I interferon responses. PLoS Pathog. 2013;9:e1003231. doi: 10.1371/journal.ppat.1003231.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1003231</ArticleId><ArticleId IdType="pmc">PMC3605153</ArticleId><ArticleId IdType="pubmed">23555247</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang W., Xiao F., Wan P., Pan P., Zhang Y., Liu F., Wu K., Liu Y., Wu J. Ev71 3d protein binds with nlrp3 and enhances the assembly of inflammasome complex. PLoS Pathog. 2017;13:e1006123. doi: 10.1371/journal.ppat.1006123.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1006123</ArticleId><ArticleId IdType="pmc">PMC5245909</ArticleId><ArticleId IdType="pubmed">28060938</ArticleId></ArticleIdList></Reference><Reference><Citation>Khong W.X., Foo D.G., Trasti S.L., Tan E.L., Alonso S. Sustained high levels of interleukin-6 contribute to the pathogenesis of enterovirus 71 in a neonate mouse model. J. Virol. 2011;85:3067&#x2013;3076. doi: 10.1128/JVI.01779-10.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01779-10</ArticleId><ArticleId IdType="pmc">PMC3067852</ArticleId><ArticleId IdType="pubmed">21228224</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang G.H., Lin L., Luo Y.J., Cai L.J., Wu X.Y., Xu H.M., Zhu Q.Y. Sequence analysis of six enterovirus 71 strains with different virulences in humans. Virus Res. 2010;151:66&#x2013;73. doi: 10.1016/j.virusres.2010.04.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2010.04.001</ArticleId><ArticleId IdType="pubmed">20398708</ArticleId></ArticleIdList></Reference><Reference><Citation>Zaini Z., McMinn P. A single mutation in capsid protein VP1 (Q145E) of a genogroup C4 strain of human enterovirus 71 generates a mouse-virulent phenotype. J. Gen. Virol. 2012;93:1935&#x2013;1940. doi: 10.1099/vir.0.043893-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.043893-0</ArticleId><ArticleId IdType="pubmed">22647370</ArticleId></ArticleIdList></Reference><Reference><Citation>Chua B.H., Phuektes P., Sanders S.A., Nicholls P.K., McMinn P.C. The molecular basis of mouse adaptation by human enterovirus 71. J. Gen. Virol. 2008;89:1622&#x2013;1632. doi: 10.1099/vir.0.83676-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.83676-0</ArticleId><ArticleId IdType="pubmed">18559932</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen Y.C., Yu C.-K., Wang Y.-F., Liu C.-C., Su I.-J., Lei H.-Y. A murine oral enterovirus 71 infection model with central nervous system involvement. J. Gen. Virol. 2004;85:69&#x2013;77. doi: 10.1099/vir.0.19423-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.19423-0</ArticleId><ArticleId IdType="pubmed">14718621</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang W., Duo J., Liu J., Ma C., Zhang L., Wei Q., Qin C. A mouse muscle-adapted enterovirus 71 strain with increased virulence in mice. Microbes Infect. 2011;13:862&#x2013;870. doi: 10.1016/j.micinf.2011.04.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.micinf.2011.04.004</ArticleId><ArticleId IdType="pubmed">21612764</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin Y.W., Chang K.C., Kao C.M., Chang S.P., Tung Y.Y., Chen S.H. Lymphocyte and antibody responses reduce enterovirus 71 lethality in mice by decreasing tissue viral loads. J. Virol. 2009;83:6477&#x2013;6483. doi: 10.1128/JVI.00434-09.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00434-09</ArticleId><ArticleId IdType="pmc">PMC2698549</ArticleId><ArticleId IdType="pubmed">19386699</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu M.L., Lee Y.-P., Liu C.-C., Yeh T.-M., Wang S.-M., Chen S.-H., Wang Y.-F., Su I.-J., Lei H.-Y., Wang J.-R., et al. Type I interferons protect mice against enterovirus 71 infection. J. Gen. Virol. 2005;86:3263&#x2013;3269. doi: 10.1099/vir.0.81195-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.81195-0</ArticleId><ArticleId IdType="pubmed">16298971</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Z.H., Li C.M., Ling P., Shen F.H., Chen S.H., Liu C.C., Yu C.K., Chen S.H. Ribavirin reduces mortality in enterovirus 71-infected mice by decreasing viral replication. J. Infect. Dis. 2008;197:854&#x2013;857. doi: 10.1086/527326.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/527326</ArticleId><ArticleId IdType="pmc">PMC7109938</ArticleId><ArticleId IdType="pubmed">18279075</ArticleId></ArticleIdList></Reference><Reference><Citation>Ong K.C., Devi S., Cardosa M.J., Wong K.T. Formaldehyde-inactivated whole-virus vaccine protects a murine model of enterovirus 71 encephalomyelitis against disease. J. Virol. 2010;84:661&#x2013;665. doi: 10.1128/JVI.00999-09.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00999-09</ArticleId><ArticleId IdType="pmc">PMC2798416</ArticleId><ArticleId IdType="pubmed">19864378</ArticleId></ArticleIdList></Reference><Reference><Citation>Ong K.C., Badmanathan M., Devi S., Leong K.L., Cardosa M.J., Wong K.T. Pathologic characterization of a murine model of human enterovirus 71 encephalomyelitis. J. Neuropathol. Exp. Neurol. 2008;67:532&#x2013;542. doi: 10.1097/NEN.0b013e31817713e7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/NEN.0b013e31817713e7</ArticleId><ArticleId IdType="pubmed">18520772</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen F.H., Tsai C.C., Wang L.C., Chang K.C., Tung Y.Y., Su I.J., Chen S.H. Enterovirus 71 infection increases expression of interferon-gamma-inducible protein 10 which protects mice by reducing viral burden in multiple tissues. J. Gen. Virol. 2013;94:1019&#x2013;1027. doi: 10.1099/vir.0.046383-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/vir.0.046383-0</ArticleId><ArticleId IdType="pubmed">23288420</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J., Dong W., Quan X., Ma C., Qin C., Zhang L. Transgenic expression of human p-selectin glycoprotein ligand-1 is not sufficient for enterovirus 71 infection in mice. Arch. Virol. 2011;157:539&#x2013;543. doi: 10.1007/s00705-011-1198-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00705-011-1198-2</ArticleId><ArticleId IdType="pubmed">22187102</ArticleId></ArticleIdList></Reference><Reference><Citation>Fujii K., Nagata N., Sato Y., Ong K.C., Wong K.T., Yamayoshi S., Shimanuki M., Shitara H., Taya C., Koike S. Transgenic mouse model for the study of enterovirus 71 neuropathogenesis. Proc. Natl. Acad. Sci. USA. 2013;110:14753&#x2013;14758. doi: 10.1073/pnas.1217563110.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1217563110</ArticleId><ArticleId IdType="pmc">PMC3767555</ArticleId><ArticleId IdType="pubmed">23959904</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin Y.-W., Yu S.-L., Shao H.-Y., Lin H.-Y., Liu C.-C., Hsiao K.-N., Chitra E., Tsou Y.-L., Chang H.-W., Sia C., et al. Human SCARB2 transgenic mice as an infectious animal model for enterovirus 71. PLoS ONE. 2013;8:e57591. doi: 10.1371/journal.pone.0057591.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0057591</ArticleId><ArticleId IdType="pmc">PMC3581494</ArticleId><ArticleId IdType="pubmed">23451246</ArticleId></ArticleIdList></Reference><Reference><Citation>Khong W.X., Yan B., Yeo H., Tan E.L., Lee J.J., Ng J.K., Chow V.T., Alonso S. A non-mouse-adapted enterovirus 71 (EV71) strain exhibits neurotropism, causing neurological manifestations in a novel mouse model of EV71 infection. J. Virol. 2012;86:2121&#x2013;2131. doi: 10.1128/JVI.06103-11.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.06103-11</ArticleId><ArticleId IdType="pmc">PMC3302383</ArticleId><ArticleId IdType="pubmed">22130542</ArticleId></ArticleIdList></Reference><Reference><Citation>Caine E.A., Partidos C.D., Santangelo J.D., Osorio J.E. Adaptation of enterovirus 71 to adult interferon deficient mice. PLoS ONE. 2013;8:e59501. doi: 10.1371/journal.pone.0059501.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0059501</ArticleId><ArticleId IdType="pmc">PMC3602422</ArticleId><ArticleId IdType="pubmed">23527208</ArticleId></ArticleIdList></Reference><Reference><Citation>Arita M., Ami Y., Wakita T., Shimizu H. Cooperative effect of the attenuation determinants derived from poliovirus sabin 1 strain is essential for attenuation of enterovirus 71 in the NOD/SCID mouse infection model. J. Virol. 2008;82:1787&#x2013;1797. doi: 10.1128/JVI.01798-07.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01798-07</ArticleId><ArticleId IdType="pmc">PMC2258712</ArticleId><ArticleId IdType="pubmed">18057246</ArticleId></ArticleIdList></Reference><Reference><Citation>Lyu K., Wang G.C., He Y.L., Han J.F., Ye Q., Qin C.F., Chen R. Crystal structures of enterovirus 71 (EV71) recombinant virus particles provide insights into vaccine design. J. Biol. Chem. 2015;290:3198&#x2013;3208. doi: 10.1074/jbc.M114.624536.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M114.624536</ArticleId><ArticleId IdType="pmc">PMC4318995</ArticleId><ArticleId IdType="pubmed">25492868</ArticleId></ArticleIdList></Reference><Reference><Citation>Ooi M.H., Wong S.C., Lewthwaite P., Cardosa M.J., Solomon T. Clinical features, diagnosis, and management of enterovirus 71. Lancet Neurol. 2010;9:1097&#x2013;1105. doi: 10.1016/S1474-4422(10)70209-X.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S1474-4422(10)70209-X</ArticleId><ArticleId IdType="pubmed">20965438</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang L.Y., King C.C., Hsu K.H., Ning H.C., Tsao K.C., Li C.C., Huang Y.C., Shih S.R., Chiou S.T., Chen P.Y., et al. Risk factors of enterovirus 71 infection and associated hand, foot, and mouth disease/herpangina in children during an epidemic in taiwan. Pediatrics. 2002;109:e88. doi: 10.1542/peds.109.6.e88.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.109.6.e88</ArticleId><ArticleId IdType="pubmed">12042582</ArticleId></ArticleIdList></Reference><Reference><Citation>Nishimura Y., Shimojima M., Tano Y., Miyamura T., Wakita T., Shimizu H. Human p-selectin glycoprotein ligand-1 is a functional receptor for enterovirus 71. Nat. Med. 2009;15:794&#x2013;797. doi: 10.1038/nm.1961.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.1961</ArticleId><ArticleId IdType="pubmed">19543284</ArticleId></ArticleIdList></Reference><Reference><Citation>Yamayoshi S., Yamashita Y., Li J., Hanagata N., Minowa T., Takemura T., Koike S. Scavenger receptor B2 is a cellular receptor for enterovirus 71. Nat. Med. 2009;15:798&#x2013;801. doi: 10.1038/nm.1992.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nm.1992</ArticleId><ArticleId IdType="pubmed">19543282</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang S.L., Chou Y.T., Wu C.N., Ho M.S. Annexin ii binds to capsid protein vp1 of enterovirus 71 and enhances viral infectivity. J. Virol. 2011;85:11809&#x2013;11820. doi: 10.1128/JVI.00297-11.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00297-11</ArticleId><ArticleId IdType="pmc">PMC3209289</ArticleId><ArticleId IdType="pubmed">21900167</ArticleId></ArticleIdList></Reference><Reference><Citation>Su P.Y., Wang Y.F., Huang S.W., Lo Y.C., Wang Y.H., Wu S.R., Shieh D.B., Chen S.H., Wang J.R., Lai M.D., et al. Cell surface nucleolin facilitates enterovirus 71 binding and infection. J. Virol. 2015;89:4527&#x2013;4538. doi: 10.1128/JVI.03498-14.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.03498-14</ArticleId><ArticleId IdType="pmc">PMC4442404</ArticleId><ArticleId IdType="pubmed">25673703</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan C.W., Poh C.L., Sam I.C., Chan Y.F. Enterovirus 71 uses cell surface heparan sulfate glycosaminoglycan as an attachment receptor. J. Virol. 2013;87:611&#x2013;620. doi: 10.1128/JVI.02226-12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.02226-12</ArticleId><ArticleId IdType="pmc">PMC3536405</ArticleId><ArticleId IdType="pubmed">23097443</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren X.X., Ma L., Liu Q.W., Li C., Huang Z., Wu L., Xiong S.D., Wang J.H., Wang H.B. The molecule of DC-SIGN captures enterovirus 71 and confers dendritic cell-mediated viral trans-infection. Virol. J. 2014;11:47. doi: 10.1186/1743-422X-11-47.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1743-422X-11-47</ArticleId><ArticleId IdType="pmc">PMC3995660</ArticleId><ArticleId IdType="pubmed">24620896</ArticleId></ArticleIdList></Reference><Reference><Citation>Fukuhara M., Iwami S., Sato K., Nishimura Y., Shimizu H., Aihara K., Koyanagi Y. Quantification of the dynamics of enterovirus 71 infection by experimental-mathematical investigation. J. Virol. 2013;87:701&#x2013;705. doi: 10.1128/JVI.01453-12.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.01453-12</ArticleId><ArticleId IdType="pmc">PMC3536373</ArticleId><ArticleId IdType="pubmed">23097444</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu P., Gao Z., Zong Y., Bao L., Xu L., Deng W., Li F., Lv Q., Gao Z., Xu Y., et al. Histopathological features and distribution of EV71 antigens and SCARB2 in human fatal cases and a mouse model of enterovirus 71 infection. Virus Res. 2014;189:121&#x2013;132. doi: 10.1016/j.virusres.2014.05.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2014.05.006</ArticleId><ArticleId IdType="pubmed">24842162</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen C.S., Yao Y.C., Lin S.C., Lee Y.P., Wang Y.F., Wang J.R., Liu C.C., Lei H.Y., Yu C.K. Retrograde axonal transport: A major transmission route of enterovirus 71 in mice. J. Virol. 2007;81:8996&#x2013;9003. doi: 10.1128/JVI.00236-07.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00236-07</ArticleId><ArticleId IdType="pmc">PMC1951457</ArticleId><ArticleId IdType="pubmed">17567704</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong K.T., Munisamy B., Ong K.C., Kojima H., Noriyo N., Chua K.B., Ong B.B., Nagashima K. The distribution of inflammation and virus in human enterovirus 71 encephalomyelitis suggests possible viral spread by neural pathways. J. Neuropathol. Exp. Neurol. 2008;67:162&#x2013;169. doi: 10.1097/nen.0b013e318163a990.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/nen.0b013e318163a990</ArticleId><ArticleId IdType="pubmed">18219253</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren R., Racaniello V.R. Poliovirus spreads from muscle to the central nervous system by neural pathways. J. Infect. Dis. 1992;166:747&#x2013;752. doi: 10.1093/infdis/166.4.747.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/166.4.747</ArticleId><ArticleId IdType="pubmed">1326581</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y., Li J., Li Q. Immune evasion of enteroviruses under innate immune monitoring. Front. Microbiol. 2018;9:1866. doi: 10.3389/fmicb.2018.01866.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2018.01866</ArticleId><ArticleId IdType="pmc">PMC6102382</ArticleId><ArticleId IdType="pubmed">30154774</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun J., Ennis J., Turner J.D., Chu J.J. Single dose of an adenovirus vectored mouse interferon-alpha protects mice from lethal EV71 challenge. Antivir. Res. 2016;134:207&#x2013;215. doi: 10.1016/j.antiviral.2016.09.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2016.09.003</ArticleId><ArticleId IdType="pmc">PMC7113890</ArticleId><ArticleId IdType="pubmed">27623347</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin H., Huang L., Zhou J., Lin K., Wang H., Xue X., Xia C. Efficacy and safety of interferon-&#x3b1;2b spray in the treatment of hand, foot, and mouth disease: A multicenter, randomized, double-blind trial. Arch. Virol. 2016;161:3073&#x2013;3080. doi: 10.1007/s00705-016-3012-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00705-016-3012-7</ArticleId><ArticleId IdType="pubmed">27518403</ArticleId></ArticleIdList></Reference><Reference><Citation>Meng G., Li M., Li Y., Wang X., Chen Q., Wei H.J.C.J.C.E.P. Severe hand-foot-mouth disease: A report of 3 autopsied cases. Chin. J. Clin. Exp. Pathol. 2011;27:48&#x2013;51.</Citation></Reference><Reference><Citation>Wang S.M., Lei H.Y., Yu C.K., Wang J.R., Su I.J., Liu C.C. Acute chemokine response in the blood and cerebrospinal fluid of children with enterovirus 71-associated brainstem encephalitis. J. Infect. Dis. 2008;198:1002&#x2013;1006. doi: 10.1086/591462.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/591462</ArticleId><ArticleId IdType="pubmed">18710325</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin Y.L., Chow Y.H., Huang L.M., Hsieh S.M., Cheng P.Y., Hu K.C., Chiang B.L. A CpG-adjuvanted intranasal enterovirus 71 vaccine elicits mucosal and systemic immune responses and protects human SCARB2-transgenic mice against lethal challenge. Sci. Rep. 2018;8:10713. doi: 10.1038/s41598-018-28281-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-018-28281-5</ArticleId><ArticleId IdType="pmc">PMC6048030</ArticleId><ArticleId IdType="pubmed">30013088</ArticleId></ArticleIdList></Reference><Reference><Citation>Chumakov M., Voroshilova M., Shindarov L., Lavrova I., Gracheva L., Koroleva G., Vasilenko S., Brodvarova I., Nikolova M., Gyurova S., et al. Enterovirus 71 isolated from cases of epidemic poliomyelitis-like disease in Bulgaria. Arch. Virol. 1979;60:329&#x2013;340. doi: 10.1007/BF01317504.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF01317504</ArticleId><ArticleId IdType="pubmed">228639</ArticleId></ArticleIdList></Reference><Reference><Citation>Nagy G., Takatsy S., Kukan E., Mihaly I., Domok I. Virological diagnosis of enterovirus type 71 infections: Experiences gained during an epidemic of acute CNS diseases in hungary in 1978. Arch. Virol. 1982;71:217&#x2013;227. doi: 10.1007/BF01314873.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/BF01314873</ArticleId><ArticleId IdType="pubmed">6285858</ArticleId></ArticleIdList></Reference><Reference><Citation>Shih S.R., Ho M.S., Lin K.H., Wu S.L., Chen Y.T., Wu C.N., Lin T.Y., Chang L.Y., Tsao K.C., Ning H.C., et al. Genetic analysis of enterovirus 71 isolated from fatal and non-fatal cases of hand, foot and mouth disease during an epidemic in taiwan, 1998. Virus Res. 2000;68:127&#x2013;136. doi: 10.1016/S0168-1702(00)00162-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0168-1702(00)00162-3</ArticleId><ArticleId IdType="pubmed">10958984</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan J.J., Su I.J., Chen P.F., Liu C.C., Yu C.K., Wang J.R. Complete genome analysis of enterovirus 71 isolated from an outbreak in taiwan and rapid identification of enterovirus 71 and coxsackievirus A16 by RT-PCR. J. Med. Virol. 2001;65:331&#x2013;339. doi: 10.1002/jmv.2038.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/jmv.2038</ArticleId><ArticleId IdType="pubmed">11536241</ArticleId></ArticleIdList></Reference><Reference><Citation>Li R., Zou Q., Chen L., Zhang H., Wang Y. Molecular analysis of virulent determinants of enterovirus 71. PLoS ONE. 2011;6:e26237. doi: 10.1371/journal.pone.0026237.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0026237</ArticleId><ArticleId IdType="pmc">PMC3198388</ArticleId><ArticleId IdType="pubmed">22039449</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang S.W., Wang Y.F., Yu C.K., Su I.J., Wang J.R. Mutations in VP2 and VP1 capsid proteins increase infectivity and mouse lethality of enterovirus 71 by virus binding and RNA accumulation enhancement. Virology. 2012;422:132&#x2013;143. doi: 10.1016/j.virol.2011.10.015.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virol.2011.10.015</ArticleId><ArticleId IdType="pubmed">22078110</ArticleId></ArticleIdList></Reference><Reference><Citation>Yeh M.T., Wang S.W., Yu C.K., Lin K.H., Lei H.Y., Su I.J., Wang J.R. A single nucleotide in stem loop II of 5&#x2032;-untranslated region contributes to virulence of enterovirus 71 in mice. PLoS ONE. 2011;6:e27082. doi: 10.1371/journal.pone.0027082.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0027082</ArticleId><ArticleId IdType="pmc">PMC3206083</ArticleId><ArticleId IdType="pubmed">22069490</ArticleId></ArticleIdList></Reference><Reference><Citation>Cordey S., Petty T.J., Schibler M., Martinez Y., Gerlach D., van Belle S., Turin L., Zdobnov E., Kaiser L., Tapparel C. Identification of site-specific adaptations conferring increased neural cell tropism during human enterovirus 71 infection. PLoS Pathog. 2012;8:e1002826. doi: 10.1371/journal.ppat.1002826.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1002826</ArticleId><ArticleId IdType="pmc">PMC3406088</ArticleId><ArticleId IdType="pubmed">22910880</ArticleId></ArticleIdList></Reference><Reference><Citation>Kobayashi K., Sudaka Y., Takashino A., Imura A., Fujii K., Koike S. Amino acid variation at VP1-145 of enterovirus 71 determines attachment receptor usage and neurovirulence in human scavenger receptor B2 transgenic mice. J. Virol. 2018 doi: 10.1128/JVI.00681-18.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/JVI.00681-18</ArticleId><ArticleId IdType="pmc">PMC6052303</ArticleId><ArticleId IdType="pubmed">29848584</ArticleId></ArticleIdList></Reference><Reference><Citation>Tseligka E.D., Sobo K., Stoppini L., Cagno V., Abdul F., Piuz I., Meylan P., Huang S., Constant S., Tapparel C. A VP1 mutation acquired during an enterovirus 71 disseminated infection confers heparan sulfate binding ability and modulates ex vivo tropism. PLoS Pathog. 2018;14:e1007190. doi: 10.1371/journal.ppat.1007190.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.ppat.1007190</ArticleId><ArticleId IdType="pmc">PMC6093697</ArticleId><ArticleId IdType="pubmed">30075025</ArticleId></ArticleIdList></Reference><Reference><Citation>McMinn P.C. An overview of the evolution of enterovirus 71 and its clinical and public health significance. FEMS Microbiol. Rev. 2002;26:91&#x2013;107. doi: 10.1111/j.1574-6976.2002.tb00601.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1574-6976.2002.tb00601.x</ArticleId><ArticleId IdType="pubmed">12007645</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang K.D., Yang M.Y., Li C.C., Lin S.F., Chong M.C., Wang C.L., Chen R.F., Lin T.Y. Altered cellular but not humoral reactions in children with complicated enterovirus 71 infections in Taiwan. J. Infect. Dis. 2001;183:850&#x2013;856. doi: 10.1086/319255.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/319255</ArticleId><ArticleId IdType="pubmed">11237800</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang L.Y., Chang I.S., Chen W.J., Huang Y.C., Chen G.W., Shih S.R., Juang J.L., Shih H.M., Hsiung C.A., Lin T.Y., et al. HLA-A33 is associated with susceptibility to enterovirus 71 infection. Pediatrics. 2008;122:1271&#x2013;1276. doi: 10.1542/peds.2007-3735.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.2007-3735</ArticleId><ArticleId IdType="pubmed">19047245</ArticleId></ArticleIdList></Reference><Reference><Citation>Li J.A., Chen Z.B., Lv T.G., Han Z.L., Liu P.P. Impact of endothelial nitric oxide synthase gene polymorphism on severity of enterovirus 71-infection in Chinese children. Clin. Biochem. 2013;46:1842&#x2013;1847. doi: 10.1016/j.clinbiochem.2013.10.009.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.clinbiochem.2013.10.009</ArticleId><ArticleId IdType="pubmed">24140479</ArticleId></ArticleIdList></Reference><Reference><Citation>Zou R., Zhang G., Li S., Wang W., Yuan J., Li J., Wang Y., Lin Y., Deng Y., Zhou B., et al. A functional polymorphism in IFNAR1 gene is associated with susceptibility and severity of HFMD with EV71 infection. Sci. Rep. 2015;5:18541. doi: 10.1038/srep18541.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep18541</ArticleId><ArticleId IdType="pmc">PMC4683517</ArticleId><ArticleId IdType="pubmed">26679744</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu F., Xu W., Xia J., Liang Z., Liu Y., Zhang X., Tan X., Wang L., Mao Q., Wu J., et al. Efficacy, safety, and immunogenicity of an enterovirus 71 vaccine in china. N. Engl. J. Med. 2014;370:818&#x2013;828. doi: 10.1056/NEJMoa1304923.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1304923</ArticleId><ArticleId IdType="pubmed">24571754</ArticleId></ArticleIdList></Reference><Reference><Citation>Li R., Liu L., Mo Z., Wang X., Xia J., Liang Z., Zhang Y., Li Y., Mao Q., Wang J., et al. An inactivated enterovirus 71 vaccine in healthy children. N. Engl. J. Med. 2014;370:829&#x2013;837. doi: 10.1056/NEJMoa1303224.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMoa1303224</ArticleId><ArticleId IdType="pubmed">24571755</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei M., Meng F., Wang S., Li J., Zhang Y., Mao Q., Hu Y., Liu P., Shi N., Tao H., et al. 2-year efficacy, immunogenicity, and safety of vigoo enterovirus 71 vaccine in healthy Chinese children: A randomized open-label study. J. Infect. Dis. 2017;215:56&#x2013;63. doi: 10.1093/infdis/jiw502.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiw502</ArticleId><ArticleId IdType="pubmed">28077584</ArticleId></ArticleIdList></Reference><Reference><Citation>Yi E.J., Shin Y.J., Kim J.H., Kim T.G., Chang S.Y. Enterovirus 71 infection and vaccines. Clin. Exp. Vaccine Res. 2017;6:4&#x2013;14. doi: 10.7774/cevr.2017.6.1.4.</Citation><ArticleIdList><ArticleId IdType="doi">10.7774/cevr.2017.6.1.4</ArticleId><ArticleId IdType="pmc">PMC5292356</ArticleId><ArticleId IdType="pubmed">28168168</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Q., Zhao B., Chen X., Song N., Wu J., Li G., Yu P., Han Y., Liu J., Qin C. GS-9620 inhibits enterovirus 71 replication mainly through the NF-kB and PI3K-AKT signaling pathways. Antivir. Res. 2018;153:39&#x2013;48. doi: 10.1016/j.antiviral.2018.02.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2018.02.002</ArticleId><ArticleId IdType="pubmed">29425831</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang X., Zhang X., Wang F., Wei H., Ma H., Sui M., Lu J., Wang H., Dumler J.S., Sheng G., et al. Clinical efficacy of therapy with recombinant human interferon alpha1b in hand, foot, and mouth disease with enterovirus 71 infection. PLoS ONE. 2016;11:e0148907.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4755579</ArticleId><ArticleId IdType="pubmed">26882102</ArticleId></ArticleIdList></Reference><Reference><Citation>Qiu S., Liu N., Jia L., Yang G., Su W., Li J., Song L., Yang C., Wang J., Zhang C., et al. A new treatment for neurogenic inflammation caused by EV71 with CR2-targeted complement inhibitor. Virol. J. 2012;9:285. doi: 10.1186/1743-422X-9-285.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1743-422X-9-285</ArticleId><ArticleId IdType="pmc">PMC3558417</ArticleId><ArticleId IdType="pubmed">23173749</ArticleId></ArticleIdList></Reference><Reference><Citation>Dai W., Wu Y., Bi J., Lu X., Hou A., Zhou Y., Sun B., Kong W., Barbier J., Cintrat J.-C., et al. Antiviral effects of Retro-2cycl and Retro-2.1 against Enterovirus 71 in vitro and in vivo. Antivir. Res. 2017;144:311&#x2013;321. doi: 10.1016/j.antiviral.2017.07.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2017.07.001</ArticleId><ArticleId IdType="pubmed">28688753</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang G., Zhou F., Gu B., Ding C., Feng D., Xie F., Wang J., Zhang C., Cao Q., Deng Y., et al. In vitro and in vivo evaluation of ribavirin and pleconaril antiviral activity against enterovirus 71 infection. Arch. Virol. 2012;157:669&#x2013;679. doi: 10.1007/s00705-011-1222-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00705-011-1222-6</ArticleId><ArticleId IdType="pubmed">22245989</ArticleId></ArticleIdList></Reference><Reference><Citation>Li M., Yang X., Guan C., Wen T., Duan Y., Zhang W., Li X., Wang Y., Zhao Z., Liu S. Andrographolide sulfonate reduces mortality in enterovirus 71 infected mice by modulating immunity. Int. Immunopharmacol. 2018;55:142&#x2013;150. doi: 10.1016/j.intimp.2017.11.042.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.intimp.2017.11.042</ArticleId><ArticleId IdType="pubmed">29253820</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J., Li X., Fan X., Ma C., Qin C., Zhang L. Adoptive transfer of macrophages from adult mice reduces mortality in mice infected with human enterovirus 71. Arch. Virol. 2013;158:387&#x2013;397. doi: 10.1007/s00705-012-1495-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00705-012-1495-4</ArticleId><ArticleId IdType="pubmed">23065110</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma J.W., Huang B.S., Hsu C.W., Peng C.W., Cheng M.L., Kao J.Y., Way T.D., Yin H.C., Wang S.S. Efficacy and safety evaluation of a chlorine dioxide solution. Int. J. Environ. Res. Public Health. 2017;14:329. doi: 10.3390/ijerph14030329.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ijerph14030329</ArticleId><ArticleId IdType="pmc">PMC5369164</ArticleId><ArticleId IdType="pubmed">28327506</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong T.W., Huang H.J., Wang Y.F., Lee Y.P., Huang C.C., Yu C.K. Methylene blue-mediated photodynamic inactivation as a novel disinfectant of enterovirus 71. J. Antimicrob. Chemother. 2010;65:2176&#x2013;2182. doi: 10.1093/jac/dkq301.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jac/dkq301</ArticleId><ArticleId IdType="pubmed">20719762</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou B., Xu L., Zhu R., Tang J., Wu Y., Su R., Yin Z., Liu D., Jiang Y., Wen C., et al. A bispecific broadly neutralizing antibody against enterovirus 71 and coxsackievirus A16 with therapeutic potential. Antivir. Res. 2019;161:28&#x2013;35. doi: 10.1016/j.antiviral.2018.11.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2018.11.001</ArticleId><ArticleId IdType="pubmed">30419253</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang H.-W., Lin Y.-W., Ho H.-M., Lin M.-H., Liu C.-C., Shao H.-Y., Chong P., Sia C., Chow Y.-H. Protective efficacy of VP1-specific neutralizing antibody associated with a reduction of viral load and pro-inflammatory cytokines in human SCARB2-transgenic mice. PLoS ONE. 2013;8:e69858. doi: 10.1371/journal.pone.0069858.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0069858</ArticleId><ArticleId IdType="pmc">PMC3728341</ArticleId><ArticleId IdType="pubmed">23936115</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang K.-T., Lin S.-J., Wang H.-C., Chen P.-C., Lin J.-J., Chiang J.-R., Chang C.-L., Shih D.Y.-C., Lo C.-F., Wang D.-Y. Establishment of an animal challenge model as a potency assay for an inactivated enterovirus type 71 vaccine. Biologicals. 2016;44:183&#x2013;190. doi: 10.1016/j.biologicals.2016.01.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.biologicals.2016.01.003</ArticleId><ArticleId IdType="pubmed">27068365</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao R.-Y., Han J.-F., Jiang T., Tian X., Yu M., Deng Y.-Q., Qin E.D., Qin C.-F. In vitro and in vivo characterization of a new enterovirus type 71-specific human intravenous immunoglobulin manufactured from selected plasma donors. J. Clin. Virol. 2011;51:246&#x2013;249. doi: 10.1016/j.jcv.2011.05.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcv.2011.05.002</ArticleId><ArticleId IdType="pubmed">21641277</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu F., Yao P.-P., Xia Y., Qian L., Yang Z.-N., Xie R.-H., Sun Y.-S., Lu H.-J., Miao Z.-P., Li C., et al. Enterovirus 71 infection causes severe pulmonary lesions in gerbils, meriones unguiculatus, which can be prevented by passive immunization with specific antisera. PLoS ONE. 2015;10:e0119173. doi: 10.1371/journal.pone.0119173.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0119173</ArticleId><ArticleId IdType="pmc">PMC4359154</ArticleId><ArticleId IdType="pubmed">25767882</ArticleId></ArticleIdList></Reference><Reference><Citation>Ho B.-C., Yu I.S., Lu L.-F., Rudensky A., Chen H.-Y., Tsai C.-W., Chang Y.-L., Wu C.-T., Chang L.-Y., Shih S.-R., et al. Inhibition of miR-146a prevents enterovirus-induced death by restoring the production of type I interferon. Nat. Commun. 2014;5:3344. doi: 10.1038/ncomms4344.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ncomms4344</ArticleId><ArticleId IdType="pubmed">24561744</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>